Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 4, 2008, Pages 625-630

  Jedpiyawongse, Adisorn ^a   Homcha em, Patcharin ^a   Karalak, Anant ^a   Srivatanakul, Petcharin ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Cervical cancer Thailand; Immunohistochemistry; p16 protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TAIWAN; UTERINE CERVIX TUMOR;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TAIWAN; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 66149116891     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Amortegui AQJ, Meyer MP, Elborne VL, et al (1995). P53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod Pathol, 8, 907-12.
2. Bagchi S, Raychaudhuri P, Nevins JR (1990). Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A transactivation. Cell, 62, 659-69.
3. Dyson N, Howley PM, Munger K, et al (1989). The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-7.
4. Ekalaksananan T, Pientong C, Sriamporn S, et al (2006). Usefulness of combinating testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Gynecol Oncol, 103, 62-6.
5. ER/PR pharmDxTM / Interpretation Manual Dako. Dako Corporate www.dako.com
6. Hawley-Nelson P, Vousden KH, Hubbert NL, et al (1989). HPV16 E6 and E7 protein cooperate to immortalize human foreskin keratinocytes. EMBO J, 8, 3905-10.
7. Herman JG, Merlo A, Mao L, et al (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 55, 4525-30.
8. Horn LC, Reichert A, Oster A, et al (2008). Immunostaining for p16INK4A used as a conjunctive tool improves interobsever agreement of the histologic diagnosis of cervical intraepithelial neoplasis. Am J Surg Pathol, 24, (Epub ahead of print)
9. IARC (1995). Human Papillomaviruses. IARC monograp on the evaluation of carcinogenic risks to humans, Vol. 65. Lyon-France: International Agency for Research on Cancer, 1995
10. Jacobs MV, Snijders PJF, Voorhorst FJ, et al (1999). Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol, 52, 498-503.
11. Keating JT, Ince T, Crum CP (2001). Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol, 8, 83-92.
12. Klaes R, Friedrich T, Spitkovsky D, et al (2001). Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer, 2, 278-84.
13. Klaes R, Benner A, Friedrich T, et al (2002). P16INK4A immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol, 26, 1389-99.
14. Koh J, Enders GH, Dynlacht BD, et al (1995). Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-10.
15. Kratzke RA, Greatens TM, Rubins JB, et al (1996). Rb and p16INK4A expression in resected non-small cell lung tumors. Cancer Res, 56, 3415-20.
16. Lechner MS, Mack DH, Finicle AB, et al (1992). Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J, 11, 3045-52.
17. Lorincz AT, Reid R, Bennett Jenson A, Greenberg MD, et al (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol, 79, 328-37.
18. Matsukura T, Sugase M (1995). Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer, 61, 13-22.
19. McCluggage WG, Walsh MY, Thornton CM, et al (1995). Interand intra-obsever variation in the histopathological reporting of cervical intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol, 105, 206-10.
20. Mitsuya I, Takuma F, Nabuo M, et al (2003). Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol, 22, 378-85.
21. Monsonego J, Pollini G, Evrard MJ, et al (2007). P16INK4A immunocytochemistry in liquid-based cytology Samples in equivocal Pap smears: added value in management of woman with equivacal Pap smear. Acta Cytol, 51, 755-66.
22. Munger K, Phelps WC, Bubb V, et al (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol, 63, 4417-21.
23. Muñoz N, and Bosch FX (1992). Review of case-control and cohort studies. In Monoz N, Bosch FX, Shaliku Z and Meheus A, (eds). The epidemiology of cervical cancer and human Papillomavirus. IARC Sciencetific Publication No.119. Lyon: IARC, 251-60.
24. Muñoz N, Bosch FX, de Sanjose S, et al (1992). The casual link between human papilloma-virus and invasive cervical cancer: a population based case control study in Colombia and Spain. Int J Cancer, 52, 743-9.
25. Murphy N, Ring M, Killalea AG, et al (2003). P16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and Thin Prep TM smears. J Clin Pathol, 56, 56-63.
26. Nakao Y, Yang X, Yokoyama M, et al (1997). Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer, 75, 1410-16.
27. Negri G, Egarter-Vigl E, Kasal A, et al (2003). P16INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol, 27, 187-93.
28. Negri G, Vittadello F, Romano F, et al (2004). P16INK4A expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch, 445, 616-20.
29. Nieh S, Chen SF, Chu TY, et al (2005). Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smear with follow-up biopsies. Gynecol Oncol, 97, 35-40.
30. Norman I, Brismar S, Zhu J, et al (2007). P16INK4A immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use? Int J Oncol, 31, 1339-43.
31. Phelps WC, Yee CL, Munger K, et al (1988). The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell, 53, 539-47.
32. Sakaguchi M, Fujii Y, Hirabayashi H, et al (1996). Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer, 65, 442-5.
33. Sano T, Oyama T, Kashiwabara K, et al (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol, 153, 1741-8.
34. Sano T, Oyama T, Kashiwabara K, et al (1998). Overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int, 48, 580-8.
35. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998). Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol International, 48, 580-85.
36. Serrano M, Hannon GJ, Beach D (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-7.
37. Shapiro GI, Edwards CD, Kobzik L, et al (1995). Reciprocal Rb inactivation and p16 expression in primary lung cancers and cell lines. Cancer Res, 55, 505-9.
38. Tam SW, Shay JW, Pagano M (1994). Differential expression and cell cycle regulation of the cyclin dependent kinase inhibitor p16 INK4A. Cancer Res, 54, 5816-20.
39. Trunk MJ, Dallenbach-Hellweg G, Ridder R, et al (2004). Morphologic characteristics of p16 INK4a-positive cells in cervical cytology samples. Acta Cytol, 48, 771-82.
40. Van de Putte G, Holm R, Lie AK, et al (2003). Expression of p27, p21 and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol, 89, 140-7.
41. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol, 189, 12-9.
42. Wentzensen N, Bergeron C, Cas F et al (2005). Evaluation of a nuclear score for p16INK4a- stained cervical squamous cells in liquid-based cytology samples. Cancer Cytopathol, 156, 461-7.
43. Werness BA, Levine AJ, Howley PM (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-9.
44. Yoshikawa H, Kawana T, Kitagawa K, et al (1991). Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res, 82, 524-31.
45. Zur Hausen H (1996). Papillomavirus infections: a major cause of human cancer. Biochim Biophys Acta, 1288, 55-78.